Hypoxia Inducible Factor Signaling and Experimental Persistent Pulmonary Hypertension of the Newborn

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2015.00047
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Persistent Pulmonary Hypertension of the Newborn: Pathophysiology and Treatment

Advances in Pulmonary Hypertension
2006English

Influence of 2‐Methoxyestradiol and Sex on Hypoxia‐Induced Pulmonary Hypertension and Hypoxia‐Inducible Factor‐1‐α

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn

Pulmonary Medicine
MedicinePulmonaryRespiratory Medicine
2011English

Clinical Syndromes and Associations With Persistent Pulmonary Hypertension of the Newborn

2011English

The Management of Persistent Pulmonary Hypertension of the Newborn: A Review

SAJCH South African Journal of Child Health
Child HealthPediatricsPerinatology
2016English

Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Suppression of the Expression of Hypoxia-Inducible Factor-1α by RNA Interference Alleviates Hypoxia-Induced Pulmonary Hypertension in Adult Rats

International Journal of Molecular Medicine
MedicineGenetics
2016English

Tracheal Bronchus With Persistent Pulmonary Hypertension of the Newborn: A Case Report

Neonatal Medicine
2017English

Treatment of Severe Persistent Pulmonary Hypertension of the Newborn With Magnesium Sulphate.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy